General MedicationsINJECTIONGeneric
DOCEFREZ
DOCETAXEL
Standard Dose
20MG/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview DOCEFREZ is listed in Drugs@FDA under application 022534 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient DOCETAXEL Form and strength INJECTABLE;INJECTION - 20MG/VIAL Sponsor SUN PHARM Submission history Latest submission status date: 2023-08-22 00:00:00.
Structured Monograph
Clinical summary
Approval overview DOCEFREZ is listed in Drugs@FDA under application 022534 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient DOCETAXEL Form and strength INJECTABLE;INJECTION - 20MG/VIAL Sponsor SUN PHARM Submission history Latest submission status date: 2023-08-22 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.